Investment
Features
FeesSafety
Academy
More
Pluang+

Niki BioSolutions' blood-based biomarker panel featured in Rett Syndrome research tool series

Market News
16 Oct 2026
GlobeNewsWire
View Source
Bullish
Niki BioSolutions' blood-based biomarker panel featured in Rett Syndrome research tool series

Niki BioSolutions, through its subsidiary DiamiR Biosciences, was highlighted in the International Rett Syndrome Foundation's "Rett Research Tool Belt" series for its development of a blood-based microRNA biomarker panel. This panel is designed to monitor disease progression and treatment response in Rett syndrome, a severe neurological disorder. The biomarker panel, tested on over 200 individuals, could provide a minimally invasive method to aid clinical trials and patient care. This recognition underscores Niki's role in advancing precision medicine for unmet medical needs.

Niki BioSolutions’ Rett Syndrome biomarker program is the subject, with Pluang market data as context. As of Oct 16, 2026 18:11 WIB, among 150 priced Health-sector US stocks tradable on Pluang, 95 rose and 42 fell. Notable movers include AMRX at USD 19.50 with a 1-day change of +1.30%, CGC at USD 0.74 with a 1-day change of +1.29% and 100% sell order activity, and NUWE at USD 0.56 with a 1-day change of +1.23%. The most notable figure is the 100% sell order activity on CGC.

More News

Nasdaq resumes trading in CN Healthy Food Tech Group Corp. after year-long halt

Nasdaq resumes trading in CN Healthy Food Tech Group Corp. after year-long halt

Nasdaq announced that trading in CN Healthy Food Tech Group Corp.'s common stock and warrants will resume on October 19, 2026, after being halted since October 1, 2025. The resumption marks the end of a year-long trading suspension, allowing investor...

Market News
Neutral
27 minutes ago
Goldman Sachs CEO David Solomon named new chair of The Business Council, succeeding Brian Cornell.

Goldman Sachs CEO David Solomon named new chair of The Business Council, succeeding Brian Cornell.

David Solomon, CEO of Goldman Sachs, has been appointed as the new chair of The Business Council, taking over from Brian Cornell, Executive Chair of Target Corporation. This leadership change comes at a critical time as the Council addresses challeng...

Market News
Bullish
27 minutes ago
SEDA Experts appoints Noor Ul Islam as Managing Director to boost risk and securities expertise.

SEDA Experts appoints Noor Ul Islam as Managing Director to boost risk and securities expertise.

SEDA Experts LLC has appointed Noor Ul Islam as Managing Director, enhancing its capabilities in risk management and securities practices. With nearly 30 years of experience at major financial institutions like Citibank and Barclays, Islam brings dee...

Others
Neutral
27 minutes ago
Global pharmaceutical market to reach $3.22T by 2035, driven by biologics, AI drug discovery, and India’s 17.1% growth in 2026

Global pharmaceutical market to reach $3.22T by 2035, driven by biologics, AI drug discovery, and India’s 17.1% growth in 2026

The global pharmaceutical market is projected to grow from USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, expanding at a CAGR of 6.15%. Growth is fueled by advances in biologics, AI-driven drug discovery, specialty drugs, and manufacturing i...

Market News
Bullish
27 minutes ago
OAAA announces winners of the 84th OBIE Awards, honoring top creative work in out of home advertising.

OAAA announces winners of the 84th OBIE Awards, honoring top creative work in out of home advertising.

The Out of Home Advertising Association of America (OAAA) held the 84th Annual OBIE Awards in New York City, celebrating the best creative campaigns in out of home (OOH) advertising. Paramount was inducted into the OBIE Hall of Fame for its longstand...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App